Literature DB >> 15344967

Cardiovascular disease in stable renal transplant patients in Norway: morbidity and mortality during a 5-yr follow-up.

Svend Aakhus1, Ketil Dahl, Tor Erik Widerøe.   

Abstract

BACKGROUND: Although cardiovascular disease is a major cause of death after renal transplantation (Tx), predictors for cardiovascular events have not been well defined. Aims of this cross-sectional study were first to assess cardiovascular morbidity and mortality in stable renal Tx patients, and to identify predictors for cardiovascular events during long-term follow-up.
METHODS: In all, 406 renal Tx patients (mean age: 47 yr, 60.1% males, 70.9% using cyclosporine A) commenced a baseline registration (median) 48 months after Tx, and 405 was thereafter followed in 5 yr. Kaplan-Meier plots and multivariate regression analysis (Cox proportional hazards model) were used to identify and characterize predictors for cardiovascular events.
RESULTS: There were 88 deaths (average annual mortality: 4.4%), and 74% of these were cardiovascular. In age groups 40-49, 50-59, and 60-69 yr, odds ratio for cardiovascular mortality in patients vs. general population was 46.2, 20.1, and 8.0, respectively. Death from ischemic heart disease (IHD) was independently predicted by baseline congestive heart failure (relative risk: RR 5.33), diabetes (RR 2.28), systolic blood pressure (mmHg, RR 1.02), age (yr, RR 1.06), and high-density lipoprotein cholesterol (mmol/L, RR 0.36). Predictors for a major ischemic heart event (death from or onset of IHD) were in addition baseline total cholesterol (mmol/L, RR 1.18) and cerebrovascular disease (RR 2.98).
CONCLUSIONS: Thus, IHD was the major cause of death late after renal Tx, and a major ischemic heart event was predicted by baseline congestive heart failure, diabetes, age, hypertension, and hypercholesterolemia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15344967     DOI: 10.1111/j.1399-0012.2004.00235.x

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  23 in total

1.  Safety and efficacy of administering the maximal dose of candesartan in renal transplant recipients.

Authors:  Masayoshi Okumi; Noritaka Kawada; Naotsugu Ichimaru; Harumi Kitamura; Toyofumi Abe; Ryoichi Imamura; Yasuyuki Kojima; Yukito Kokado; Yoshitaka Isaka; Hiromi Rakugi; Norio Nonomura; Toshiki Moriyama; Shiro Takahara
Journal:  Clin Exp Nephrol       Date:  2011-08-05       Impact factor: 2.801

Review 2.  Physical inactivity: a risk factor and target for intervention in renal care.

Authors:  Dorien M Zelle; Gerald Klaassen; Edwin van Adrichem; Stephan J L Bakker; Eva Corpeleijn; Gerjan Navis
Journal:  Nat Rev Nephrol       Date:  2017-01-31       Impact factor: 28.314

Review 3.  Exercise training in kidney transplant recipients: a systematic review.

Authors:  Patrizia Calella; Sonsoles Hernández-Sánchez; Carlo Garofalo; Jonatan R Ruiz; Juan J Carrero; Vincenzo Bellizzi
Journal:  J Nephrol       Date:  2019-01-16       Impact factor: 3.902

Review 4.  The impact of vitamin D deficiency on patients undergoing kidney transplantation: focus on cardiovascular, metabolic, and endocrine outcomes.

Authors:  Gerardo Sarno; Giuseppe Daniele; Giacomo Tirabassi; Alberto O Chavez; Opeolu O Ojo; Francesco Orio; Hana Kahleova; Giancarlo Balercia; William B Grant; Paride De Rosa; Annamaria Colao; Giovanna Muscogiuri
Journal:  Endocrine       Date:  2015-05-22       Impact factor: 3.633

Review 5.  Cardiac imaging for the assessment of patients being evaluated for kidney or liver transplantation.

Authors:  Kalindi Parikh; Andrew Appis; Rami Doukky
Journal:  J Nucl Cardiol       Date:  2014-10-08       Impact factor: 5.952

Review 6.  Primary care of the renal transplant patient.

Authors:  Gaurav Gupta; Mark L Unruh; Thomas D Nolin; Peggy B Hasley
Journal:  J Gen Intern Med       Date:  2010-04-27       Impact factor: 5.128

7.  Long-term cardiovascular outcomes in type 1 diabetic patients after simultaneous pancreas and kidney transplantation compared with living donor kidney transplantation.

Authors:  Jørn P Lindahl; Anders Hartmann; Svend Aakhus; Knut Endresen; Karsten Midtvedt; Hallvard Holdaas; Torbjørn Leivestad; Rune Horneland; Ole Øyen; Trond Jenssen
Journal:  Diabetologia       Date:  2015-12-28       Impact factor: 10.122

8.  Low physical activity and risk of cardiovascular and all-cause mortality in renal transplant recipients.

Authors:  Dorien M Zelle; Eva Corpeleijn; Ronald P Stolk; Mathieu H G de Greef; Rijk O B Gans; Jaap J Homan van der Heide; Gerjan Navis; Stephan J L Bakker
Journal:  Clin J Am Soc Nephrol       Date:  2011-03-03       Impact factor: 8.237

9.  Death with functioning kidney transplant: an obituarial analysis.

Authors:  Puneet Sood; Yong R Zhu; Eric P Cohen
Journal:  Int Urol Nephrol       Date:  2010-06-03       Impact factor: 2.370

10.  Induction immunosuppression agents as risk factors for incident cardiovascular events and mortality after kidney transplantation.

Authors:  Shaifali Sandal; Sunjae Bae; Mara McAdams-DeMarco; Allan B Massie; Krista L Lentine; Marcelo Cantarovich; Dorry L Segev
Journal:  Am J Transplant       Date:  2018-12-06       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.